Dr. Richard I Fisher M.D.
Hematologist-Oncologist | Hematology & Oncology
601 Elmwood Ave # 704 Rochester NY, 14642About
Dr. Richard Fisher is a hematologist oncologist practicing in Rochester, NY. Dr. Fisher specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Harvard Med Sch, Boston Ma 1970
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993.
- Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin's lymphoma.
- Phase II trial of menogaril in non-Hodgkin's lymphomas: a Southwest Oncology Group trial.
- Long-term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma.
- Diffuse large-cell lymphoma.
- Characterization of the lymphocyte surface receptors for Con A and PHA.
- Autologous bone marrow transplantation for aggressive non-Hodgkin's lymphoma: lessons learned and challenges remaining.
- Infusional CHOP chemotherapy (CVAD) with or without chemosensitizers offers no advantage over standard CHOP therapy in the treatment of lymphoma: a Southwest Oncology Group Study.
- Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma.
- Current therapeutic paradigm for the treatment of non-Hodgkin's lymphoma.
- The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features.
- Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: results of two phase II cytokine working group trials.
- Treating Hodgkin's disease with bispecific antibodies: Both patients and antibody are limiting.
- The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin's lymphoma: an evidence-based review.
- Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's disease.
Dr. Richard I Fisher M.D.'s Practice location
Dr. Richard I Fisher M.D.'s reviews
Write ReviewPatient Experience with Dr. Fisher
Recommended Articles
- Tips for Young Adult Lymphoma Survivors to Make the Most of Recovery
It is extremely difficult to reenter the world and normal life after battling lymphoma. Recovery is much more than the body's physical battle, but how to balance emotions and relationships as well.However, there are specific tools that can assist in adapting back into a life that may seem...
- How to Show Social Support for Lymphoma
A cancer diagnosis can shake an individual’s world, and not just the physical aspects of their world, but all corners of it. Although cancer attacks the body, it necessarily also affects a person’s mental and emotional state, and it can have an impact on other people close to the affected...
- Nurse Donates Breast Milk for Lymphoma Patient's Baby
Ashley Chestnut, a mother of two children from La Vista, Nebraska, was breastfeeding her 5-month-year-old son Easton when she began to experience a sharp and sudden pain in her shoulder and chest. “All of a sudden a sharp pain in my shoulder and chest, it was like hitting a freight train. It was...
- 'Robocop' Stem Cells Developed to Fight Cancer
Cancer is the second-leading cause of death in the United States, although due to several advancements in cancer screening and treatment, survival rates have begun to improve.A new cancer therapyResearchers at the University of Minnesota and Mayo Clinic have developed a new type of cancer therapy...
- The Leukemia & Lymphoma Society to Expand Mission Against Blood Cancer
On July 19, 2017, the Leukemia & Lymphoma Society, or LLS, proclaimed that they would be expanding their initiative to beat acute myeloid leukemia. Referred to as "Beat AML Master Trial", the project aims to test new and innovative treatments for those suffering from AML. For more information...
- Treatments for Multiple Myeloma
The cancer care crew discusses what treatment will suit you after multiple myeloma has been diagnosed and staged. The following are treatments used in multiple myeloma:...
Nearby Providers
- Mr. Neil Nagovski MD601 Elmwood Ave Rochester NY 14642
- Dr. William Muuse MD601 ELMWOOD AVE ROCHESTER NY 14642
- Dr. Ruth M O'regan MD601 ELMWOOD AVE ROCHESTER NY 14642
- Dr. John M Bennett M.D.601 Elmwood Avenue Rochester NY 14642
- Dr. Mohamedtaki Abdulaziz Tejani M.D.601 Elmwood Avenue Rochester NY 14642
- Dr. Adam S Kotowski MD601 Elmwood Ave Rochester NY 14642